Loading...
XIST
DEVA
Market cap296mUSD
Nov 12, Last price  
62.90TRY
Name

Deva Holding AS

Chart & Performance

D1W1MN
XIST:DEVA chart
P/E
181.23
P/S
0.81
EPS
0.35
Div Yield, %
0.40%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
62.27%
Revenues
15.46b
+36.43%
230,278,587181,921,280267,264,880216,985,507332,640,465385,659,898404,973,563419,510,418418,391,085467,940,004576,380,100688,456,364800,295,1121,040,677,0481,373,983,5411,863,328,5012,330,367,7914,477,917,31311,330,314,02115,458,482,050
Net income
69m
-97.95%
14,463,629-48,872,14090,605,540-91,433,418-8,185,395-1,600,891-15,633,95534,240,84324,603,6708,722,94247,659,66860,331,10192,542,675136,361,117286,015,741651,448,6841,170,087,4761,360,224,2213,385,418,49169,419,646
CFO
5.07b
+119.36%
5,997,776-28,468,790-60,216,170-73,313,673-18,698,883480,740-4,592,2616,537,89350,037,22351,491,51288,579,902187,441,072110,844,831130,983,784441,236,234637,391,8701,247,774,934815,910,9802,310,120,8995,067,374,239
Dividend
Jun 25, 20240.25 TRY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs. In addition, the company offers cephalosporins, penicillin, inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.
IPO date
Mar 24, 1986
Employees
Domiciled in
TR
Incorporated in
TR

Valuation

Title
TRY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT